ProLung Advises Shareholders to Disregard Former CEO’s Steven Eror’s Recent Illegal Press Release – ProLung,...
Read More
Additions Bring Extensive Operating Experience in Medical Technology and Diagnostics as well as Repeated Success...
Read More
Letter to Shareholders (Sept 2018) from Jared Bauer, interim CEO – ProLung, Inc. Dear ProLung Shareholders...
Read More
ProLung, Inc. Announces Organizational Changes to Sharpen Focus on Achieving FDA Approval and Successful Commercialization...
Read MoreProLung, Inc. Releases Communication Urging Stockholders Not to Respond to Consent Solicitation by Steven C....
Read MoreProLung, Inc. Releases Communication Urging Stockholders Not to Respond to Consent Solicitation by Steven C....
Read More
ProLung Recognized with "2018's Most Innovative Predictive Analytics Award" by Corporate Vision – ProLung, Inc. SALT...
Read MoreProLung Named Top Ten Analytics Solution Provider by Pharma Tech Outlook – ProLung, Inc. ProLung is...
Read More
ProLung recognized with '2018 Utah Innovation Award' by Stoel Rives and Utah Technology Council –...
Read MoreMDDI Feature: ProLung Breathes Life Into Lung Cancer Detection – ProLung, Inc. ProLung is hoping to...
Read More
ProLung Recognized with '2018 Biotechnology Award' by Global Health & Pharma – ProLung, Inc. SALT LAKE...
Read MoreProLung Featured in MedTech Strategist’s “Start-Ups to Watch” – ProLung, Inc. ProLung is honored to be...
Read More